Bristol-Myers Squibb announces appointment of Francis Cuss as Executive Vice President and CSO, effective July 1; Elliott Sigal plans to retire
7 April 2013 | By Bristol-Myers Squibb Company
The appointment of Francis Cuss announced...
List view / Grid view
7 April 2013 | By Bristol-Myers Squibb Company
The appointment of Francis Cuss announced...
5 April 2013 | By AstraZeneca
AstraZeneca announced top-line results of OSKIRA-1...
4 April 2013 | By Azbil BioVigilant
UT to implement ABV’s rapid microbial monitoring in new aseptic processing area...
4 April 2013 | By Roche
The Elecsys Calcitonin marker expands Roche’s portfolio for improved thyroid management
4 April 2013 | By Biogen Idec
Results from the DAC HYP SELECT clinical trial...
3 April 2013 | By GlaxoSmithKline
GSK announced the start of a Phase III study...
3 April 2013 | By kdm communications limited
Pharmaceutical developers at Synthon have chosen an Optim 1000 high throughput, micro-volume protein analysis system...
3 April 2013 | By GlobalData
India is becoming a key market for generic medicines...
3 April 2013 | By Johnson & Johnson
“CELLSEARCH® the first and only FDA-cleared CTC test..."
3 April 2013 | By Pfizer
CHOP and Pfizer are joining forces...
3 April 2013 | By FTI Consulting
GW has obtained a patent in the US...
3 April 2013 | By GlaxoSmithKline
Marketing authorisation for quadrivalent (four-strain) influenza vaccine...
3 April 2013 | By AstraZeneca
AstraZeneca announced that MedImmune has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company...
2 April 2013 | By Munro & Forster
Sunovion Europe has formally changed its name from Dainippon Sumitomo Pharma Europe Ltd. (DSPE)...
2 April 2013 | By AbbVie
AbbVie announced that the European Commission has approved an extension of the EC marketing authorization for HUMIRA...